IP Library Granted Patent US 7,951,546
Granted Patent B2
US 7,951,546 · App. 12/156,180 · Granted May 31, 2011

Compositions and methods for the diagnosis and treatment of tumor

Assignee: Genetech, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,951,546
App. No.
12/156,180
Granted
May 31, 2011
Kind
B2
Abstract

The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.

Claims (4)

1. A method of diagnosing the presence of colon cancer in a mammal, said method comprising contacting a test sample of tissue cells suspected of containing cancerous tumor cells obtained from said mammal with an anti-SEQ ID NO:92 antibody that specifically binds to a protein comprising the amino acid sequence of SEQ ID NO:92, and detecting the formation of a complex between said antibody and said protein in the test sample, and classifying a higher level of formation of such a complex in the test sample, as compared to the level of formation of such a complex in a control sample of normal tissue cells from the same type of tissue as the test sample, as diagnostic of the presence of colon cancer in said mammal.

2. The method of claim 1 , wherein said anti-SEQ ID NO: 92 antibody is detectably labeled.

3. A method of diagnosing the presence of colon cancer in a mammal, said method comprising determining the level of expression of a gene encoding a protein comprising the amino acid sequence of SEQ ID NO:92 in a test sample of tissue cells obtained from tissue suspected of containing cancerous tumor cells in said mammal and in a control sample of known normal cells taken from the same type of tissue as the test sample, wherein determining the level of expression of a gene encoding said protein comprises employing an anti-SEQ ID NO:92 antibody that specifically binds to a protein comprising the amino acid sequence of SEQ ID NO:92, and classifying a higher level of expression of said protein in the test sample, as compared to the control sample, as diagnostic of the presence of colon cancer in the mammal from which the test sample was obtained.

4. The method of claim 3 , wherein the step employing an anti-SEQ ID NO:92 antibody that specifically binds to a protein comprising the amino acid sequence of SEQ ID NO:92 comprises an immunohistochemistry or Western blot analysis.

Continuity (11)
Continuation 11804045 · May 15, 2007
Continuation 10872972 · Jun 21, 2004
Continuation 10241220 · Sep 11, 2002
Provisional Application 60323268 · Sep 18, 2001
Provisional Application 60339227 · Oct 19, 2001
Provisional Application 60336827 · Nov 7, 2001
Provisional Application 60331906 · Nov 20, 2001
Provisional Application 60345444 · Jan 2, 2002
Provisional Application 60369724 · Apr 3, 2002
Provisional Application 60404809 · Aug 19, 2002
Related Publication 20090075279A1 · Mar 19, 2009